Overall, our findings indicated that CTSV downregulates adhesion molecules such as fibronectin, E-cadherin, and N-cadherin, which may suggest that CTSV is a potential therapeutic target for halting lung cancer spread. This evidence concerns the gene CDH1 and lung carcinoma.